These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28712920)

  • 1. Amelioration of cirrhotic portal hypertension by targeted cyclooxygenase-1 siRNA delivery to liver sinusoidal endothelium with polyethylenimine grafted hyaluronic acid.
    Lin L; Cai M; Deng S; Huang W; Huang J; Huang X; Huang M; Wang Y; Shuai X; Zhu K
    Nanomedicine; 2017 Oct; 13(7):2329-2339. PubMed ID: 28712920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Target specific systemic delivery of TGF-β siRNA/(PEI-SS)-g-HA complex for the treatment of liver cirrhosis.
    Park K; Hong SW; Hur W; Lee MY; Yang JA; Kim SW; Yoon SK; Hahn SK
    Biomaterials; 2011 Jul; 32(21):4951-8. PubMed ID: 21481451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronic acid reagent functional chitosan-PEI conjugate with AQP2-siRNA suppressed endometriotic lesion formation.
    Zhao MD; Cheng JL; Yan JJ; Chen FY; Sheng JZ; Sun DL; Chen J; Miao J; Zhang RJ; Zheng CH; Huang HF
    Int J Nanomedicine; 2016; 11():1323-36. PubMed ID: 27099493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Target specific tumor treatment by VEGF siRNA complexed with reducible polyethyleneimine-hyaluronic acid conjugate.
    Park K; Lee MY; Kim KS; Hahn SK
    Biomaterials; 2010 Jul; 31(19):5258-65. PubMed ID: 20378167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human amniotic stem cells improve hepatic microvascular dysfunction and portal hypertension in cirrhotic rats.
    Pietrosi G; Fernández-Iglesias A; Pampalone M; Ortega-Ribera M; Lozano JJ; García-Calderó H; Abad-Jordà L; Conaldi PG; Parolini O; Vizzini G; Luca A; Bosch J; Gracia-Sancho J
    Liver Int; 2020 Oct; 40(10):2500-2514. PubMed ID: 32996708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Target specific intracellular delivery of siRNA/PEI-HA complex by receptor mediated endocytosis.
    Jiang G; Park K; Kim J; Kim KS; Hahn SK
    Mol Pharm; 2009; 6(3):727-37. PubMed ID: 19178144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronic acid-polyethyleneimine conjugate for target specific intracellular delivery of siRNA.
    Jiang G; Park K; Kim J; Kim KS; Oh EJ; Kang H; Han SE; Oh YK; Park TG; Kwang Hahn S
    Biopolymers; 2008 Jul; 89(7):635-42. PubMed ID: 18322932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cluster of Differentiation 44 Targeted Hyaluronic Acid Based Nanoparticles for MDR1 siRNA Delivery to Overcome Drug Resistance in Ovarian Cancer.
    Yang X; Iyer AK; Singh A; Milane L; Choy E; Hornicek FJ; Amiji MM; Duan Z
    Pharm Res; 2015 Jun; 32(6):2097-109. PubMed ID: 25515492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. siRNA-loaded selenium nanoparticle modified with hyaluronic acid for enhanced hepatocellular carcinoma therapy.
    Xia Y; Guo M; Xu T; Li Y; Wang C; Lin Z; Zhao M; Zhu B
    Int J Nanomedicine; 2018; 13():1539-1552. PubMed ID: 29588583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Target-specific gene silencing of layer-by-layer assembled gold-cysteamine/siRNA/PEI/HA nanocomplex.
    Lee MY; Park SJ; Park K; Kim KS; Lee H; Hahn SK
    ACS Nano; 2011 Aug; 5(8):6138-47. PubMed ID: 21739990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Celecoxib reduces hepatic vascular resistance in portal hypertension by amelioration of endothelial oxidative stress.
    Tai Y; Zhao C; Zhang L; Tang S; Jia X; Tong H; Liu R; Tang C; Gao J
    J Cell Mol Med; 2021 Nov; 25(22):10389-10402. PubMed ID: 34609050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversible Covalent Cross-Linked Polycations with Enhanced Stability and ATP-Responsive Behavior for Improved siRNA Delivery.
    Zhou Z; Zhang M; Liu Y; Li C; Zhang Q; Oupicky D; Sun M
    Biomacromolecules; 2018 Sep; 19(9):3776-3787. PubMed ID: 30081638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient and Tumor Targeted siRNA Delivery by Polyethylenimine-graft-polycaprolactone-block-poly(ethylene glycol)-folate (PEI-PCL-PEG-Fol).
    Liu L; Zheng M; Librizzi D; Renette T; Merkel OM; Kissel T
    Mol Pharm; 2016 Jan; 13(1):134-43. PubMed ID: 26641134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology and a Rational Basis of Therapy.
    Gracia-Sancho J; Maeso-Díaz R; Bosch J
    Dig Dis; 2015; 33(4):508-14. PubMed ID: 26159267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel biotinylated chitosan-graft-polyethyleneimine copolymer as a targeted non-viral vector for anti-EGF receptor siRNA delivery in cancer cells.
    Darvishi MH; Nomani A; Amini M; Shokrgozar MA; Dinarvand R
    Int J Pharm; 2013 Nov; 456(2):408-16. PubMed ID: 24012865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunonano-Lipocarrier-Mediated Liver Sinusoidal Endothelial Cell-Specific RUNX1 Inhibition Impedes Immune Cell Infiltration and Hepatic Inflammation in Murine Model of NASH.
    Tripathi DM; Rohilla S; Kaur I; Siddiqui H; Rawal P; Juneja P; Kumar V; Kumari A; Naidu VGM; Ramakrishna S; Banerjee S; Puria R; Sarin SK; Kaur S
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combinational siRNA delivery using hyaluronic acid modified amphiphilic polyplexes against cell cycle and phosphatase proteins to inhibit growth and migration of triple-negative breast cancer cells.
    Parmar MB; Meenakshi Sundaram DN; K C RB; Maranchuk R; Montazeri Aliabadi H; Hugh JC; Löbenberg R; Uludağ H
    Acta Biomater; 2018 Jan; 66():294-309. PubMed ID: 29183848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cationic derivatives of biocompatible hyaluronic acids for delivery of siRNA and antisense oligonucleotides.
    Han SE; Kang H; Shim GY; Kim SJ; Choi HG; Kim J; Hahn SK; Oh YK
    J Drug Target; 2009 Feb; 17(2):123-32. PubMed ID: 19012052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arachidonic acid metabolites and endothelial dysfunction of portal hypertension.
    Sacerdoti D; Pesce P; Di Pascoli M; Brocco S; Cecchetto L; Bolognesi M
    Prostaglandins Other Lipid Mediat; 2015 Jul; 120():80-90. PubMed ID: 26072731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging and therapy of liver fibrosis using bioreducible polyethylenimine/siRNA complexes conjugated with N-acetylglucosamine as a targeting moiety.
    Kim SJ; Ise H; Kim E; Goto M; Akaike T; Chung BH
    Biomaterials; 2013 Sep; 34(27):6504-14. PubMed ID: 23726228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.